Clinical Trials Browser

Phase 2 × anlotinib × Dermatologic × Clear all

NCT06327698 2024-03-25

Cadonilimab in Combination With Anlotinib in the Treatment of Locally Progressive or Metastatic Melanoma With First-Line Therapy Failure

Phase 2 Not yet recruiting

Melanoma

NCT04979585 2021-08-03

Camrelizumab Plus Amlotinib and Chemotherapy in the First-line Treatment of Melanoma

Phase 2 Unknown

Melanoma